Results 111 to 120 of about 267,158 (314)

Essential work, invisible workers: The role of digital curation in COVID‐19 Open Science

Journal of the Association for Information Science and Technology, Volume 76, Issue 4, Page 703-717, April 2025.
Abstract In this paper, we examine the role digital curation practices and practitioners played in facilitating open science (OS) initiatives amid the COVID‐19 pandemic. In Summer 2023, we conducted a content analysis of available information regarding 50 OS initiatives that emerged—or substantially shifted their focus—between 2020 and 2022 to address ...
Irene V. Pasquetto, Amina A. Abdu, Natascha Chtena   +2 more
wiley   +1 more source

Identification of novel neutralizing determinants for protection against HCV

Hepatology, EarlyView., 2022
Identification of novel neutralizing determinants for protection against hepatitis C virus. Abstract Background and Aims HCV evasion of neutralizing antibodies (nAb) results in viral persistence and poses challenges to the development of an urgently needed vaccine.
Garazi P. Alzua, Anne F. Pihl, Anna Offersgaard, Rodrigo Velázquez‐Moctezuma, Carlos R. Duarte Hernandez, Elias H. Augestad, Ulrik Fahnøe, Christian K. Mathiesen, Henrik Krarup, Mansun Law, Jannick Prentoe, Jens Bukh, Judith M. Gottwein   +12 more
wiley   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double‐blind, placebo‐controlled clinical trial

Hepatology, EarlyView., 2022
NRPT 1X reduces ALT and ceramide 14:0 in 65% of subjects as compared to only 28% in the placebo group. Abstract Background and Aims The prevalence of NAFLD is increasing globally and on a path to becoming the most frequent cause of chronic liver disease. Strategies for the prevention and treatment of NAFLD are urgently needed.
Ryan W. Dellinger, Holly E. Holmes, Tina Hu‐Seliger, Rodney W. Butt, Stephen A. Harrison, Dariush Mozaffarian, Oliver Chen, Leonard Guarente   +7 more
wiley   +1 more source

Human mobility in epidemic modeling

Physics Reports
79 pages, 13 figures, 5 ...
Xin Lu, Jiawei Feng, Shengjie Lai, Petter Holme, Shuo Liu, Zhanwei Du, Xiaoqian Yuan, Siqing Wang, Yunxuan Li, Xiaoyu Zhang, Yuan Bai, Xiaojun Duan, Wenjun Mei, Hongjie Yu, Suoyi Tan, Fredrik Liljeros   +15 more
openaire   +2 more sources

Research on Multi-Agent Simulation of Epidemic News Spread Characteristics [PDF]

The spread of news about an epidemic can easily lead to a social panic. In order to devise measures to control such a panic, it is necessary to consider characteristics of the spread of epidemic news, based on mechanisms at the individual level.
Renbin Xiao, Xiaoguang Gong
core  

Zuranolone: A case study in (regulatory) rush to judgement?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove, Milutin Kostic, Barbara Mintzes, Gianna D'Ambrozio, Allen Shaughnessy   +4 more
wiley   +1 more source

Dynamics of Worm Propagation Model in Complex Networks Considering Benign Worm and Link Prediction Approach

Engineering Reports
In this paper, the spread of worms as a type of malware is modeled with epidemic models. In the proposed model, we have considered the defense mechanism of the benign worm, link prediction, and quarantine of the infected nodes as methods to reduce the ...
Elham Asadi, Soodeh Hosseini
doaj   +1 more source

A Routing Table Poisoning Model for Peer-to-Peer (P2P) Botnets

IEEE Access, 2019
Due to the global increase in mobile devices and cellular networks such as 3G, 4G, or LTE-A networks, the concept of the interpenetration of peer-to-peer (P2P) overlay networks in cellular environments has gained immense popularity among mobile users ...
Sumit Kumar Tetarave, Somanath Tripathy, Ezhil Kalaimannan, Caroline John, Anshika Srivastava   +4 more
doaj   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source